# Enfusion, Inc.

Enfusion, Inc. is a company headquartered in Chicago, IL, United States.

## Company overview

- **Legal name:** Enfusion, Inc.
- **Classification:** Company
- **Industry (SIC):** 7372 — Services-Prepackaged Software
- **Headquarters:** Chicago, IL, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001868912

## About

Enfusion, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001868912, and its reported industry is Services-Prepackaged Software. In 10-K filed on 2025-03-03, it reported annual revenue of USD 201,611,000; net income of USD 2,823,000; total assets of USD 143,261,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $201.6M (USD 201,611,000)
- **Net income:** $2.8M (USD 2,823,000)
- **Total assets:** $143.3M (USD 143,261,000)
- **Cash and equivalents:** $54.5M (USD 54,480,000)
- **Operating cash flow:** $34.7M (USD 34,682,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $174.5M (USD 174,535,000)
- **Net income:** $6.0M (USD 6,025,000)
- **Total assets:** $109.0M (USD 108,972,000)
- **Cash and equivalents:** $35.6M (USD 35,604,000)
- **Operating cash flow:** $25.6M (USD 25,634,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $150.3M (USD 150,349,000)
- **Net income:** -$7.7M (USD -7,654,000)
- **Total assets:** $123.8M (USD 123,783,000)
- **Cash and equivalents:** $62.5M (USD 62,545,000)
- **Operating cash flow:** $14.2M (USD 14,156,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $111.7M (USD 111,700,000)
- **Net income:** -$158.3M (USD -158,317,000)
- **Total assets:** $106.1M (USD 106,085,000)
- **Cash and equivalents:** $64.4M (USD 64,365,000)
- **Operating cash flow:** -$318,000 (USD -318,000)

## Recent SEC filings

- Form 8-K — filed 2025-04-21 — period 2025-04-21 — FORM 8-K
- Form 10-K/A — filed 2025-04-21 — period 2024-12-31 — 10-K/A
- Form 8-K — filed 2025-04-17 — period 2025-04-17 — FORM 8-K
- Form 8-K — filed 2025-04-17 — period 2025-04-17 — FORM 8-K
- Form 8-K — filed 2025-04-11 — period 2025-04-10 — FORM 8-K
- Form 8-K — filed 2025-04-02 — period 2025-04-02 — FORM 8-K
- Form 10-K — filed 2025-03-03 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-03 — period 2025-03-03 — 8-K
- Form 8-K — filed 2025-02-27 — period 2025-02-26 — FORM 8-K
- Form 8-K — filed 2025-01-13 — period 2025-01-10 — FORM 8-K
- Form 10-Q — filed 2024-11-04 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-04 — period 2024-11-04 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/enfusion-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology